rs104895151

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_000243.3(MEFV):​c.1370C>T​(p.Ala457Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,614,008 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A457A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00015 ( 1 hom. )

Consequence

MEFV
NM_000243.3 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:9B:1O:1

Conservation

PhyloP100: -1.51

Publications

8 publications found
Variant links:
Genes affected
MEFV (HGNC:6998): (MEFV innate immunity regulator, pyrin) This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008]
MEFV Gene-Disease associations (from GenCC):
  • familial Mediterranean fever
    Inheritance: AD, AR, SD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, ClinGen
  • autosomal recessive familial Mediterranean fever
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • familial Mediterranean fever, autosomal dominant
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036343336).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MEFVNM_000243.3 linkc.1370C>T p.Ala457Val missense_variant Exon 5 of 10 ENST00000219596.6 NP_000234.1 O15553-2
MEFVNM_001198536.2 linkc.737C>T p.Ala246Val missense_variant Exon 4 of 9 NP_001185465.2 O15553-3D2DTW2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEFVENST00000219596.6 linkc.1370C>T p.Ala457Val missense_variant Exon 5 of 10 1 NM_000243.3 ENSP00000219596.1 O15553-2

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
152184
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00806
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000271
AC:
68
AN:
251348
AF XY:
0.000258
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00496
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000528
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000148
AC:
217
AN:
1461824
Hom.:
1
Cov.:
33
AF XY:
0.000142
AC XY:
103
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.000201
AC:
9
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00513
AC:
134
AN:
26136
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53358
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000306
AC:
34
AN:
1112008
Other (OTH)
AF:
0.000397
AC:
24
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
12
24
36
48
60
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
152184
Hom.:
0
Cov.:
31
AF XY:
0.000175
AC XY:
13
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41440
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00806
AC:
28
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000418
Hom.:
0
Bravo
AF:
0.000178
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000231
AC:
28
EpiCase
AF:
0.000327
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:9Benign:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Familial Mediterranean fever Uncertain:2Benign:1Other:1
May 28, 2019
Mendelics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Unité médicale des maladies autoinflammatoires, CHRU Montpellier
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not provided Uncertain:3
Jul 15, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported as heterozygous in an individual with fibromyalgia syndrome and an unrelated individual with FMF and small fiber neuropathy; both individuals were also heterozygous for the E148Q, P369S and R408Q variants, with all 4 variants on the same allele (in cis) (PMID: 20041150, 32133669); In silico analysis suggests that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27332769, 29579081, 32133669, 34426522, 32806879, 20041150, 29599418, 29927949, 30476936, 25203624) -

Jun 06, 2017
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The MEFV c.1370C>T; p.Ala457Val variant (rs104895151) has been reported in an individual with periodic fever syndrome (Infevers database), and another individual with fibromyalgia syndrome (Feng 2009). However, in the latter case, the variant was paternally inherited, and found in-cis with p.Glu148Gln, p.Pro369Ser and p.Arg408Gln, with no variants detected on the maternal chromosome (Feng 2009). The variant is listed in ClinVar (Variation ID: 97441), and observed in the general population at an overall frequency of 0.03% (73/277128 alleles) in the Genome Aggregation Database. The alanine at residue 457 is weakly conserved and computational algorithms (PolyPhen-2, SIFT) predict that the variant has no impact on the protein. Due to the limited information regarding this variant, its clinical significance cannot be determined with certainty. References: Infevers database: http://fmf.igh.cnrs.fr/ISSAID/infevers/search.php?n=1 Feng J et al. Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels. PLoS One. 2009;4(12):e8480. -

May 01, 2017
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial Mediterranean fever;C0085077:Acute febrile neutrophilic dermatosis;C1851347:Familial Mediterranean fever, autosomal dominant Uncertain:2
Mar 30, 2021
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MEFV NM_000243.2 exon 5 p.Ala457Val (c.1370C>T): This variant has been reported in the literature in at least 2 individuals with features of Familial Mediterranean Fever (FMF). This variant is often reported in cis with several other variants (p.Glu148Gln, p.Pro369Ser, p.Arg408Gln) as part of a complex heterozygote; however at least 1 individual was reported to have this variant in trans (Lainka 2012 PMID:22903357, Mneimneh 2016 PMID:n/a). Of note, this variant was also found in cis with the same variants in 1 patient with fibromyalgia (Feng 2009 PMID:20041150). This variant is present in 0.5% (54/10368) of Ashkenazi Jewish alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/16-3297233-G-A?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:97441) and the infevers database (https://infevers.umai-montpellier.fr/web/detail_mutation.php). This variant amino acid Valine (Val) is present in 9 species and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

May 05, 2022
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

not specified Uncertain:1
Jun 14, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: MEFV c.1370C>T (p.Ala457Val) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00028 in 252058 control chromosomes (gnomAD). This frequency is not higher than expected for a pathogenic variant in MEFV causing Familial Mediterranean Fever (0.00028 vs 0.022), allowing no conclusion about variant significance. c.1370C>T has been reported in the literature in individuals affected with Familial Mediterranean Fever (Lainka_2012, Mneimneh_2016). It was also reported in one heterozygous patient presented with Fibromyalgia Syndrome who had inherited the variant from his apparently unaffected heterozygous father (Fen_2009). These reports do not provide unequivocal conclusions about association of the variant with Familial Mediterranean Fever. Recently, the International Study Group for Systemic Autoinflammatory Diseases (INSIAD) involving experts on hereditary recurrent fever genetics, provided a classification of likely benign with a provisional status for c.1370C>T (Van Gijn_2018). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance until additional data of functional or clinical significance become available. -

Familial Mediterranean fever;C1851347:Familial Mediterranean fever, autosomal dominant Uncertain:1
Mar 20, 2020
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MEFV NM_000243.2 exon 5 p.Ala457Val (c.1370C>T): This variant has been reported in the literature in at least 2 individuals with features of Familial Mediterranean Fever (FMF). This variant is often reported in cis with several other variants (p.Glu148Gln, p.Pro369Ser, p.Arg408Gln) as part of a complex heterozygote; however at least 1 individual was reported to have this variant in trans (Lainka 2012 PMID:22903357, Mneimneh 2016 PMID:n/a). Of note, this variant was also found in cis with the same variants in 1 patient with fibromyalgia (Feng 2009 PMID:20041150). This variant is present in 0.5% (54/10368) of Ashkenazi Jewish alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/16-3297233-G-A?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:97441) and the infevers database (https://infevers.umai-montpellier.fr/web/detail_mutation.php). This variant amino acid Valine (Val) is present in 9 species and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
0.26
DANN
Benign
0.49
DEOGEN2
Benign
0.27
T;.;.;.
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.038
N
LIST_S2
Benign
0.26
T;T;T;T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.0036
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.60
N;.;.;.
PhyloP100
-1.5
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.050
N;N;N;N
REVEL
Benign
0.28
Sift
Benign
0.068
T;T;T;T
Sift4G
Uncertain
0.030
D;D;T;D
Polyphen
0.0
B;.;.;.
Vest4
0.056
MVP
0.49
MPC
0.11
ClinPred
0.012
T
GERP RS
-4.4
Varity_R
0.052
gMVP
0.075
Mutation Taster
=11/89
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs104895151; hg19: chr16-3297233; API